Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.
Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser
Naro Antonino, Billeri Luana, Corpina Flavio, Ferlazzo Marco, Criaco Fabio, Fugazzotto Domenico
Objective: Tracking cognitive impairment in patients with coronavirus disease 2019 (COVID-19) requires objective markers to monitor therapy responses and prognosticate neurological recovery. We sought to assess if quantitative EEG (QEEG) analysis could help identifying peculiar features suggesting COVID-19 related encephalopathy regardless of brain damage related to pulmonary failure.
Methods: A patient, who survived to a severe respiratory failure due to COVID-19 pneumonia, developed a severe neurocognitive syndrome. The patient underwent QEEG monitoring (global coherence, GC) before after one month of intensive cardiopulmonary and motor rehabilitation.
Results: We found a high-frequency strong central-temporal-parietal connectivity at baseline. This was replaced by low-frequency frontal-parietal connectivity. EEG signals and their modifications were unrelated to the former acute respiratory failure.
Conclusion: A decrease of front parietal GC in the upper alpha and beta band in resting state may be a key feature of COVID-19-related encephalopathy. This may depend on a virus-induced brain damage causing loss of connections that are essential to orchestrate the interactions between brain regions at a global level concerning cognitive functions. Significance: Our data suggest that assessing GC seems promising to evidence a frontoparietal connectivity impairment sustaining the COVID-19 neurocognitive syndrome. Once confirmed in larger samples, these QEEG findings may support clinicians in the management and prognosis of COVID-19 patients.